205 related articles for article (PubMed ID: 31257076)
21. Calcium channel blocker use reduces incident dementia risk in elderly hypertensive patients: A meta-analysis of prospective studies.
Hussain S; Singh A; Rahman SO; Habib A; Najmi AK
Neurosci Lett; 2018 Apr; 671():120-127. PubMed ID: 29452176
[TBL] [Abstract][Full Text] [Related]
22. Evidence-based evaluation of calcium channel blockers for hypertension: equality of mortality and cardiovascular risk relative to conventional therapy.
Opie LH; Schall R
J Am Coll Cardiol; 2002 Jan; 39(2):315-22. PubMed ID: 11788225
[TBL] [Abstract][Full Text] [Related]
23. Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker.
Tsai MS; Tang CH; Lin CY; Chuang PY; Chen NC; Huang CH; Chang WT; Wang TD; Yu PH; Chen WJ
Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):535-543. PubMed ID: 29218625
[TBL] [Abstract][Full Text] [Related]
24. Association of calcium channel blockers with lower incidence of intracranial aneurysm rupture and growth in hypertensive patients.
Liu Q; Li J; Zhang Y; Leng X; Mossa-Basha M; Levitt MR; Wang S; Zhu C
J Neurosurg; 2023 Sep; 139(3):651-660. PubMed ID: 36708539
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients.
Griffith TF; Chua BS; Allen AS; Klassen PS; Reddan DN; Szczech LA
Am J Kidney Dis; 2003 Dec; 42(6):1260-9. PubMed ID: 14655199
[TBL] [Abstract][Full Text] [Related]
26. Survival benefit from calcium channel blockers in elderly blacks following acute myocardial infarction.
Williams D; Kim KS; Adams-Campbell LL
Ethn Dis; 2002; 12(2):229-33. PubMed ID: 12019932
[TBL] [Abstract][Full Text] [Related]
27. Antihypertensive agents and the risk of breast cancer in women aged 55 years and older: a nested case-control study.
Chang CH; Chiang CH; Yen CJ; Wu LC; Lin JW; Lai MS
J Hypertens; 2016 Mar; 34(3):558-66; discussion 566. PubMed ID: 26818924
[TBL] [Abstract][Full Text] [Related]
28. Patients with rheumatoid arthritis have impaired long-term outcomes after myocardial infarction: a nationwide case-control registry study.
Palomäki A; Kerola AM; Malmberg M; Rautava P; Kytö V
Rheumatology (Oxford); 2021 Nov; 60(11):5205-5215. PubMed ID: 33667301
[TBL] [Abstract][Full Text] [Related]
29. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.
Maradit-Kremers H; Crowson CS; Nicola PJ; Ballman KV; Roger VL; Jacobsen SJ; Gabriel SE
Arthritis Rheum; 2005 Feb; 52(2):402-11. PubMed ID: 15693010
[TBL] [Abstract][Full Text] [Related]
30. Calcium channel blockade to prevent stroke in hypertension: a meta-analysis of 13 studies with 103,793 subjects.
Angeli F; Verdecchia P; Reboldi GP; Gattobigio R; Bentivoglio M; Staessen JA; Porcellati C
Am J Hypertens; 2004 Sep; 17(9):817-22. PubMed ID: 15363825
[TBL] [Abstract][Full Text] [Related]
31. Calcium channel blockers in the spectrum of antihypertensive agents.
Liebson PR
Expert Opin Pharmacother; 2006 Dec; 7(17):2385-401. PubMed ID: 17109613
[TBL] [Abstract][Full Text] [Related]
32. Depression increases risk of incident myocardial infarction among Veterans Administration patients with rheumatoid arthritis.
Scherrer JF; Virgo KS; Zeringue A; Bucholz KK; Jacob T; Johnson RG; True WR; Carney RM; Freedland KE; Xian H; Caplan L; McDonald J; Eisen SA
Gen Hosp Psychiatry; 2009; 31(4):353-9. PubMed ID: 19555796
[TBL] [Abstract][Full Text] [Related]
33. Influence of calcium channel blockers in patients with gastrointestinal disease in Japanese community pharmacies.
Hamada A; Akiyoshi R; Ishii J; Hamada N; Miyazaki C; Hamada T; Ohwaki Y; Ikeda R; Wada M; Nakashima K
J Clin Pharm Ther; 2012 Feb; 37(1):74-7. PubMed ID: 21395634
[TBL] [Abstract][Full Text] [Related]
34. Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study.
Dong YH; Alcusky M; Maio V; Liu J; Liu M; Wu LC; Chang CH; Lai MS; Gagne JJ
BMJ Open; 2017 Mar; 7(3):e012997. PubMed ID: 28363921
[TBL] [Abstract][Full Text] [Related]
35. Use of cardioselective β-blockers and overall death and cardiovascular outcomes in patients with COPD: a population-based cohort study.
Dong YH; Chang CH; Wu LC; Lai MS
Eur J Clin Pharmacol; 2016 Oct; 72(10):1265-1273. PubMed ID: 27444174
[TBL] [Abstract][Full Text] [Related]
36. Retrospective longitudinal cohort study comparing the effects of angiotensin-converting enzyme inhibitors and long-acting calcium channel blockers on total and cardiovascular mortality in patients with hypertension.
Tardif JC; Ducharme A; Yu H; Wogen J; Guertin MC
Clin Ther; 2004 Jul; 26(7):1073-83. PubMed ID: 15336472
[TBL] [Abstract][Full Text] [Related]
37. Myocardial infarction in newly diagnosed hypertensive Medicaid patients free of coronary heart disease and treated with calcium channel blockers.
Leader SG; Mallick R; Briggs NC
Am J Med; 1997 Feb; 102(2):150-7. PubMed ID: 9217564
[TBL] [Abstract][Full Text] [Related]
38. Antihypertensives and myocardial infarction risk: the modifying effect of history of drug use.
Bourgault C; Elstein E; Baltzan MA; Le Lorier J; Suissa S
Pharmacoepidemiol Drug Saf; 2001; 10(4):287-94. PubMed ID: 11760488
[TBL] [Abstract][Full Text] [Related]
39. Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.
Chaugai S; Sherpa LY; Sepehry AA; Kerman SRJ; Arima H
J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):433-445. PubMed ID: 29739234
[TBL] [Abstract][Full Text] [Related]
40. Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients.
Kloner RA; Vetrovec GW; Materson BJ; Levenstein M
Am J Cardiol; 1998 Jan; 81(2):163-9. PubMed ID: 9591899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
